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Purpose: The purpose of our study was to determine the prevalence of spinal cord lesions
revealed by magnetic resonance (MR) imaging in children and adolescents with clinically
deﬁnite multiple sclerosis (MS).
Material and methods: We retrospectively evaluated the spinal cord magnetic resonance
examinations in a group of MS patients consisting of 58 children (37 girls and 21 boys) aged
from 7 to 17.8 years (mean 13.7 years). All children met the criteria of clinically deﬁnite MS
and had typical MS lesions revealed in the brain imaging.
Results: Spinal cord lesions, regardless of localization, were identiﬁed in 36 (62%) patients. In
22 of 58 patients (38%) no lesions were observed. The plaques were found in the cervical
spinal cord and the thoracic spinal cord in 30 out of 36 (86.1%) and in 31 out of 36 (88.6%)
patients, respectively. Contrast enhancement was noticed in 10 out of 36 patients (27.7%) and
was not correlated with the number of lesions present.
We noticed a tendency to higher EDSS score in patients with lesions in more than 1 spinal
cord region.
Our study showed that spinal cord lesions are more frequently present in patients with
complex neurological disability.
Conclusion: The prevalence of spinal cord lesions in children and adolescents with MS is high.
Therefore, spinal cord MRI should be included in diagnostic program of MS.
© 2016 Published by Elsevier Sp. z o.o. on behalf of Polish Neurological Society.
Available online at www.sciencedirect.com
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Multiple sclerosis (MS) is a chronic inﬂammatory, demyelin-
ating, neurodegenerative disease of the central nervous* Corresponding author at: Department of Diagnostic Imaging, The Ch
Warsaw, Poland. Tel.: +48 22 8152284; fax: +48 22 81512 76.
E-mail address: joanna.ewa.debska@gmail.com (J. Dębska).
http://dx.doi.org/10.1016/j.pjnns.2016.11.008
0028-3843/© 2016 Published by Elsevier Sp. z o.o. on behalf of Polish Nsystem. The disorder is most commonly diagnosed between
ages 20 and 40, but can be seen at any age, including children
and adolescents.
The term ‘‘pediatric MS’’ is applied to children with MS (<10
years of age) and adolescents (<18 years of age) [1]. About 2.2–ildren's Health Memorial Institute, Al. Dzieci Polskich 20, 04-730
eurological Society.
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age of 16, less than 1% before 11 years of age [1–5]. The
diagnosis is based primarily on clinical ﬁndings; however,
laboratory tests and magnetic resonance imaging (MRI) play an
important role in the diagnostic process [1,6–8]. Magnetic
resonance imaging is a method of choice for demonstrating
abnormalities of the brain and spinal cord tissue, as well as
lesions dissemination in space and time [2,8,9].
Following the recommendation of the International Pedi-
atric MS Study Group the MR examination should include a
cranial and a spinal MRI with and without gadolinium [2].
However, although brain MRI is performed routinely in MS
children, only few articles relating to lesions in the spinal cord
[10] with the use of contrast media in children with MS have
been published [11].
In Poland, limited use of spinal cord MRI in MS patients is
related also to the requirements of the national program of MS
therapy reimbursement, which include brain MRI only as an
outcome measure (www.nfz.gov.pl).
The aim of our study was to describe the MR features and to
determine the prevalence of spinal cord lesions revealed by
magnetic resonance (MR) imaging in children and adolescents
with clinically deﬁnite multiple sclerosis, based on the
diagnostic criteria proposed by the International Pediatric
MS Study Group.
2. Material and methods
Our series included 58 children who fulﬁlled the criteria for
relapsing–remitting MS and were treated in the Department of
Neurology and Epileptology at out hospital between 2010 and
2013. The group of patients consisted of 37 girls (63.7%), aged
from 8.2 to 17.8 years, mean age 14.4 and 21 boys (36.2%) aged
from 7 to 16.7, mean age 13.4 years.
We retrospectively evaluated the ﬁrst spinal cord magnetic
resonance examinations which were the part of routine
radiological investigations of each MS patients. Both cranial
and spinal exams were performed.
MRI of the spinal cord was performed on 1.5T scanner using
a spinal phased array coil.
The MRI protocol consisted of T1-, T2-weighted sagittal and
axial images visualizing the entire length of the spinal cord.
The contrast medium is given for patients in whom lesions
were found in the spinal cord; T1-weighted images in two
planes following gadolinium administration in dose of
0.1 mmol/kg were obtained.
The parameters used for the sagittal T1-weighted sequence
were as follows: repetition time/echo time: TR/TE = 486/10 ms,
acquisition matrix = 269  384, ﬁeld of view
FOV = 340  340 mm, slice thickness 3 mm, gap 10%, averages
4; for T2-weighted: TR/TE = 3400/103 ms, acquisition
matrix = 358  512, FOV = 340  340, thickness 3 mm, gap
10%. The parameters used for axial T1-weighted: TR/
TE = 751/12 ms, FOV = 250  250, matrix = 185  384, thickness
4 mm; for axial T2-weighted: 3910/107 ms, FOV = 250  250,
matrix = 245  384, thickness 4 mm. Acquisition time for
spinal cord imaging was approximately 30 min.
The following features of MR images were analyzed: the
presence of focal or diffuse lesions seen on T2-weightedimages on both planes, lesion location, total lesions count and
the number of enhancing lesions.
The spinal cord involvement is described as the presence of
high intensity lesions on T2 weighted images, single, multiple
or diffuse, with or without enhancement after contrast
injection. The presence and number of enhancing lesions
was scored in the spinal cord on T1-weighted images after
contrast injection.
All spinal cord MRI scans were reviewed by consensus by
two experienced neuroradiologists with minimum 15 years of
experience in neuroradiology.
All patients underwent thorough clinical workout, includ-
ing EDSS score. Clinical symptoms associated with spinal cord
lesions were determined in ﬁve domains: motor, sensory,
bowel or urinary disturbances and abnormal reﬂexes. Abnor-
mal spinal reﬂexes included any disturbances in superﬁcial
abdominal or cremasteric (in males only) reﬂexes. Neurologi-
cal status of the patients at the time point when spinal cord
MRI was performed was taken into account.
3. Results
First spinal cord MRI was performed during ﬁrst relapse of the
disease in 36 (62%) of the disease, up to 3 months after ﬁrst
relapse in 10 (17.2%) patients, during second relapse in 5
patients (8.6%), and later on the course of the disease in 7 cases
(12%).
Spinal cord lesions were disclosed in 22 patients out of 36
with spinal cord MRI performed during ﬁrst MS relapse (61%),
in 7 out of 10 with MRI performed up 3 months after ﬁrst
relapse in (70%) patients, in 4 out of 5 with MRI performed
during second relapse (90%), and in 3 out of 7 with MRI
performed later on the course of the disease (42.8%).
Spinal cord lesions, regardless of localization, were identi-
ﬁed in 36 (62%) patients. In 22 of 58 patients (37.9%) no lesions
were observed. The plaques were found in the cervical spinal
cord and the thoracic spinal cord in 30 (52%) and in 31 (53%)
patients, respectively. The number of lesions differed accord-
ing to spinal cord segments. In the cervical spinal cord there
were 67 lesions while in the thoracic region we observed 63
lesions (Fig. 1).
The lesions were found in only in the cervical spine in 5
children, only in the thoracic spine in 6 patients. Both
segments were affected in 25 patients. 4 of 31 patients
(11.1%) had uncountable, diffuse lesions.
Contrast enhancement was noticed in 10 out of 36 patients
(27.7%). In 3 patients their only one lesion in the cervical spinal
cord showed enhancement. One patient had one lesion in the
thoracic spine which showed gadolinium enhancement. In 5
patients lesions in both evaluated segments enhanced.
MRI data are summarized in Table 1.
4. Clinical presentation of spinal cord lesions
in MS children and adolescents
Mean EDSS score in MS children and adolescents at the time
spinal MRI was performed was 1.6 (median EDSS – 1) and
ranged from 0.5 to 5. Clinical signs and symptoms associated
Fig. 1 – Coronal (a) and sagittal (b) T2WI shows multiple
hyperintensive lesions in the cervical (a and b) and thoracic
(a) spinal cord.
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Twenty- seven patients (46.6%) presented with both clinical
symptoms and concordant spinal cord lesions on MRI. In 9
(15.5%) patients spinal cord lesions disclosed on MRI were
clinically silent. Eight (13.8%) patients presented with clinical
symptoms despite no lesions on spinal cord MRI.
Most common clinical symptoms included abnormal
superﬁcial reﬂexes (in 37 patients, 100% of symptomatic
cases), motor loss (13 patients, 35.1% of symptomatic cases),
sensory loss (6 patients, 16.2% of symptomatic cases), urinaryincontinence (6 patients, 16.2% of symptomatic cases), and
constipation (4 patients, 10.8% of symptomatic cases).
In the group of patients whose MRI examination showed
spinal lesions, the most common symptom were abnormal
reﬂexes – 27 of 36 (75%) patients presented with them. In this
subgroup, other clinical symptoms included motor loss (11
patients out of 36 in this group, 30.6%), sensory loss (4 patients
out of 36 in this group, 11.1%), urinary incontinence (4 patients
out of 36 in this group, 11.1%), and constipation (3 patients out
of 36 in this group, 8.3%).
In patients with normal spinal MRI, clinical symptoms
included abnormal superﬁcial reﬂexes (10 patients out of 22 in
this group, 45.5%), motor loss (2 patients out of 22 in this group,
9%), sensory loss (2 patients out of 22 in this group, 9%), urinary
incontinence (2 patients out of 22 in this group, 9%), and
constipation (1 patients out of 22 in this group, 4.5%).
Complex neurological symptoms, affecting more than 1
clinical domain was present in 21 (34.4%) patients and was
more common in patients with MRI lesions in spinal cord (16
out of 36 patients; 44.4%) than in patients with normal MRI (5
out of 22 patents; 22.7%).
Only one patient presented with contrast enhancing
lesions (1 out of 10; 10%) and no clinical symptoms. In patients
with contrast enhancing lesions, ﬁve (50%) presented with
complex neurological symptoms, affecting more than 1
clinical domain.
Diffuse uncountable MRI lesions were seen only in
symptomatic patients. Patients with both C and Th/L regions
affected were more frequently symptomatic (21 out of 25
patients; 84%) than asymptomatic (4 out of 25 patients; 16%).
EDSS score in this subgroup of patients was up to 2 in 16 cases
(64%) and above 2 in 9 cases (36%).
5. Discussion
MRI is nowadays one of the basic tools in diagnosing MS and
in monitoring progress of the disease [1,4,5,12]. Most studies
until now have focused on cranial MR examinations in adult
patients. Recently, spinal cord involvement has been
studied more closely [13–15]. It is estimated that about
80% of patients may present spinal cord symptoms during
onset of the disease [2]. It is generally thought that in
pediatric MS lesions in the spine do not signiﬁcantly differ
from those found in adults in terms of localization, length or
number [5,8].
In our study, we have taken into consideration 58 spinal
cord examinations, the most numerous group evaluated so far
when it comes to pediatric population. The only other study
concerning exclusively spinal cord lesions in ped-MS assessed
36 patients [11].
Spinal cord lesions were found in 36 out of 58 patients (62%),
which proved to be far less than previously described-Verhey
et al. reported lesions in 29 out of 38 patients (81%).
In our patients, spinal cord lesions were present with high
frequency from the onset of clinical activity of the disease,
clinical symptoms of spinal cord involvement during the ﬁrst
MS relapse were limited to the patients with spinal cord
lesions disclosed on MRI examination, and presence of spinal
cord MRI lesions was not seen in symptomatic cases only,
Table 1
No. Sex Years at
investigation
Cervical
region
Thoracic
region
Clinical symptoms EDSS
No. of
lesions
Gad No. of
lesions
Gad Motor
loss
Sensory
disturbances
Abnormal
reﬂexes
Constipation Urinary
incontinence
1 F 12 d.u. No 3 No  + +   1.5
2 F 16.8 0  1 No      1
3 M 14.9 1 Yes 0 No +  +   1
4 M 12 5 Yes 5 Yes      3.5
5 F 8.5 3 No 5 No +  +   2
6 M 8 d.u. Yes d.u. Yes +  +   3
7 M 14.3 5 No 1 No   +   1
8 F 15.5 6 Yes 4 Yes +  + + + 2.5
9 F 12.8 1 No 0       1
10 F 9.3 1 NO 3 No      1
11 F 11.3 0  1 No   +   2
12 F 17 1 No 1 No      1
13 M 7 1 Yes 0  + + +   5
14 M 15 0  1 No      1
15 M 15.8 3 No 4 No +  +   2
16 F 14.4 1 No 3 No +  + +  2
17 M 17 0  1 No +  +   3
18 F 10.8 2 No 1 No +  +   2
19 M 16.3 4 No 3 No +  +   2.5
20 F 16.8 1 No 0    +   1.5
21 F 13.4 3 No 0       1.5
22 F 17.8 3 No 1 No      1.5
23 F 12.8 1 No 2 Yes   +   1.5
24 F 11.6 3 No 3 No   +   3
25 F 16.8 5 No 2 No   +   1
26 M 15.9 2 No 1 No   +   2
27 F 17.3 3 No 6 No   +  + 2
28 F 15.7 d.u. No d.u. No + + +   4.5
29 F 15.3 1 Yes 1 Yes      1.5
30 F 16.8 6 No 6 Yes   +   2.5
31 M 16.7 2 Yes 1  +  +   2.5
32 M 13.4 0  1 No   +   3
33 M 16.2 1 No 1 No +  +  1
34 M 11.5 0  1 No +  + + + 3
35 M 13.3 d.u. No 2 No   +   2.5
36 F 15.4 2 Yes 1 Yes   +   2
d.u. – diffuse uncountable.
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beginning of the disease, even before its clinical activity.
We report that lesions in the spinal cord were more
commonly situated in the thoracic regions, however the
difference between the occurrence of the lesions in the
thoracic vs the cervical segments did not vary signiﬁcantly
(53% vs 52%). This is not consistent with previous studies, as it
is generally thought that in pediatric MS lesions in the spine
are observed predominantly in the cervical region [2,10,11], in
which they do not differ from those in adults [5,8]. In
particular, Verhey et al. found lesions in the cervical region
in 11 patients (31%), while lesions in the thoracic region were
observed in 9 (25%) children and both regions were involved in
9 patients (25%).
The number of detected lesions varied according to spinal
region; in our population of 58 patients in the cervical region
there were 67 plaques (1.86 per patient) and in the thoracic
region 63 plaques were observed (1.75 per patient). Four
patients had diffuse uncountable lesions in the cervical and
two of them also in the thoracic segment. Once again, our datado not correspond with the previously published study. Verhey
et al. reported 30 lesions in the cervical spinal cord and 27 in
the thoracic region, which constituted, respectively, 50% and
45% of the number of lesions.
As for the enhancement after the administration of
gadolinium contrast, we observed the enhancement in 8
patients (14%) in the cervical spinal cord and in 7 (12%) patients
in the thoracic spinal cord, but in ﬁve patients lesions in both
segments showed enhancement. In general, these patients
constituted 28% of our population. Verhey analyzed only 16
examinations after contrast injection, as some of the patients
refused the procedure or had previous allergic reaction and 5
children had gadolinium enhancing lesions (31%), which is not
a dramatic difference in comparison to what we report.
In terms of clinical disability, the authors found no
correlation between the EDSS of patients and the lesion load
[18]. In our study we noticed a tendency to higher EDSS score in
patients with lesions in more than 1 spinal cord region.
Our study showed that spinal cord lesions are more
frequently present in patients with complex neurological
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cord involvement are seen both in patients with normal and
abnormal spinal cord MRI. Other neurological signs and
symptoms, including urinary incontinence and spinal sensory
or motor loss are more frequent among patients with
abnormal MRI, although may be seen also in patients with
normal MRI.
In the attempt to increase diagnostic value of MRI
examination, new imaging techniques have been investigated.
The use of MR elastography, magnetization transfer imaging,
diffusion transfer imaging and spectroscopy have recently
been studied [16–19]. They offer unprecedented insight into
tissue microstructure and mechanical properties, showing
pathological lesions earlier than traditional MR sequences.
Their place in diagnosing MS has not yet been established, but
it is thought that, in time, they may become valuable tools in
diagnosing MS.
6. Conclusion
Spinal cord lesions in MS children and adolescents are
frequently seen and can be clinically silent. Numerous MRI
spinal cord plaques are more common in patients with
complex neurological disability. Spinal cord MRI examination
facilitates making a prompt and accurate diagnosis, helping to
prove e.g. dissemination in space. Therefore, spinal cord MRI
should be included in diagnostic program as one of the basic
examinations.
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